On the public citation graph

Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment

https://doi.org/10.1093/annonc/mdx330
0 signed · 158 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/9781444300710openalex-snapshot
Sample Size Tables for Clinical Studies
inferredcites →https://doi.org/10.1002/jso.23936openalex-snapshot
KRAS discordance between primary and recurrent tumors after radical resection of colorectal cancers
inferredcites →https://doi.org/10.1007/s10555-016-9629-xopenalex-snapshot
Origins, structures, and functions of circulating DNA in oncology
inferredcites →https://doi.org/10.1016/j.cca.2013.05.022openalex-snapshot
Circulating cell free DNA: Preanalytical considerations
inferredcites →https://doi.org/10.1016/j.cca.2014.03.024openalex-snapshot
Comparison of KRAS mutation analysis of primary tumors and matched circulating cell-free DNA in plasmas of patients with colorectal cancer
inferredcites →https://doi.org/10.1016/j.clcc.2015.10.006openalex-snapshot
RAS Mutations as Predictive Biomarkers in Clinical Management of Metastatic Colorectal Cancer
inferredcites →https://doi.org/10.1016/j.molonc.2014.02.005openalex-snapshot
Multi‐marker analysis of circulating cell‐free DNA toward personalized medicine for colorectal cancer
inferredcites →https://doi.org/10.1016/s1470-2045(10)70130-3openalex-snapshot
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
inferredcites →https://doi.org/10.1016/s1470-2045(14)70330-4openalex-snapshot
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
inferredcites →https://doi.org/10.1016/s1470-2045(15)00138-2openalex-snapshot
Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial
inferredcites →https://doi.org/10.1038/bjc.2011.26openalex-snapshot
KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients
inferredcites →https://doi.org/10.1038/modpathol.2011.60openalex-snapshot
Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls
inferredcites →https://doi.org/10.1038/nature11219openalex-snapshot
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
inferredcites →https://doi.org/10.1038/nature12065openalex-snapshot
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
inferredcites →https://doi.org/10.1038/ng.3214openalex-snapshot
A Big Bang model of human colorectal tumor growth
inferredcites →https://doi.org/10.1038/nm.1789openalex-snapshot
Circulating mutant DNA to assess tumor dynamics
inferredcites →https://doi.org/10.1038/nm.3511openalex-snapshot
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
inferredcites →https://doi.org/10.1038/nm.3870openalex-snapshot
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
inferredcites →https://doi.org/10.1038/nm0715-827bopenalex-snapshot
Erratum: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
inferredcites →https://doi.org/10.1038/nrc3066openalex-snapshot
Cell-free nucleic acids as biomarkers in cancer patients
inferredcites →https://doi.org/10.1056/nejmoa1113205openalex-snapshot
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
inferredcites →https://doi.org/10.1093/annonc/mds620openalex-snapshot
Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer
inferredcites →https://doi.org/10.1093/annonc/mdu141openalex-snapshot
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer
inferredcites →https://doi.org/10.1093/annonc/mdu312.5openalex-snapshot
Non-Invasive Analysis of Acquired Resistance to Cancer Therapy By Sequencing of Plasma Dna
inferredcites →https://doi.org/10.1093/annonc/mdw235openalex-snapshot
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
inferredcites →https://doi.org/10.1093/nar/gkq421openalex-snapshot
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
inferredcites →https://doi.org/10.1126/scitranslmed.3007094openalex-snapshot
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
inferredcites →https://doi.org/10.1158/0008-5472.can-06-0191openalex-snapshot
KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer
inferredcites →https://doi.org/10.1158/0008-5472.can-15-3457openalex-snapshot
Improving the Performance of Somatic Mutation Identification by Recovering Circulating Tumor DNA Mutations
inferredcites →https://doi.org/10.1158/1078-0432.ccr-11-1965openalex-snapshot
Primary Colorectal Cancers and Their Subsequent Hepatic Metastases Are Genetically Different: Implications for Selection of Patients for Targeted Treatment
inferredcites →https://doi.org/10.1158/1078-0432.ccr-14-0983openalex-snapshot
Clinical Relevance of KRAS -Mutated Subclones Detected with Picodroplet Digital PCR in Advanced Colorectal Cancer Treated with Anti-EGFR Therapy
inferredcites →https://doi.org/10.1158/1078-0432.ccr-15-0297openalex-snapshot
Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care
inferredcites →https://doi.org/10.1158/1078-0432.ccr-17-0232openalex-snapshot
Circulating DNA Demonstrates Convergent Evolution and Common Resistance Mechanisms during Treatment of Colorectal Cancer
inferredcites →https://doi.org/10.1186/1471-2407-12-347openalex-snapshot
Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
inferredcites →https://doi.org/10.1200/jco.2007.14.7116openalex-snapshot
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
inferredcites →https://doi.org/10.1200/jco.2012.45.2011openalex-snapshot
Liquid Biopsies: Genotyping Circulating Tumor DNA
inferredcites →https://doi.org/10.1200/jco.2014.59.4812openalex-snapshot
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and RAS Mutations in Colorectal Cancer
inferredcites →https://doi.org/10.1200/jop.2015.007898openalex-snapshot
Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015 Summary
inferredcites →https://doi.org/10.1371/journal.pone.0023418openalex-snapshot
High Fragmentation Characterizes Tumour-Derived Circulating DNA
inferredcites →https://doi.org/10.1371/journal.pone.0047020openalex-snapshot
Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers
inferredcites →https://doi.org/10.1593/tlo.12445openalex-snapshot
Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load
inferredcites →https://doi.org/10.18632/oncoscience.118openalex-snapshot
RAS mutations vary between lesions in synchronous primary Colorectal Cancer: Testing only one lesion is not sufficient to guide anti-EGFR treatment decisions.
inferredcites →https://doi.org/10.18632/oncotarget.13915openalex-snapshot
Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer
inferredcites →https://doi.org/10.2174/156800912799095162openalex-snapshot
Analysis of the Concordance in the EGFR Pathway Status Between Primary Tumors and Related Metastases of Colorectal Cancer Patients:Implications for Cancer Therapy
inferredcites →https://doi.org/10.3310/hta18320openalex-snapshot
Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis
inferredcites →https://doi.org/10.3310/hta18620openalex-snapshot
KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysis
inferredcites →https://doi.org/10.5858/arpa.2013-0649-oaopenalex-snapshot
Challenges Posed to Pathologists in the Detection of KRAS Mutations in Colorectal Cancers

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3912217openalex-extracted
Association of the Neutrophil Extracellular Traps Formation With the Production of Circulating Cell-Free DNA and Anti-Cardiolipin Autoantibody in Patients With a Metastatic Colorectal Cancer
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2021.24483openalex-snapshot
Association of COVID-19 Lockdown With the Tumor Burden in Patients With Newly Diagnosed Metastatic Colorectal Cancer
inferred← citeshttps://doi.org/10.1002/1878-0261.12672openalex-snapshot
Concordance between TP53 alterations in blood and tissue: impact of time interval, biopsy site, cancer type and circulating tumor DNA burden
inferred← citeshttps://doi.org/10.1002/1878-0261.12972openalex-snapshot
Monitoring levels of circulating cell‐free DNA in patients with metastatic colorectal cancer as a potential biomarker of responses to regorafenib treatment
inferred← citeshttps://doi.org/10.1002/1878-0261.13778openalex-snapshot
Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer—results from the FIRE ‐4.5 study
inferred← citeshttps://doi.org/10.1007/978-1-4939-8973-7_3openalex-snapshot
Circulating Cell-Free DNA and Cancer Therapy Monitoring: Methods and Potential
inferred← citeshttps://doi.org/10.1007/978-3-030-00362-3_18openalex-snapshot
Targeted Therapeutics for Lymphoma: Using Biology to Inform Treatment
inferred← citeshttps://doi.org/10.1007/978-981-13-3050-6_9openalex-snapshot
Chemotherapy for Metastatic Colorectal Cancer
inferred← citeshttps://doi.org/10.1007/s10555-020-09913-7openalex-snapshot
Current therapy of advanced colorectal cancer according to RAS/RAF mutational status
inferred← citeshttps://doi.org/10.1007/s10897-018-0289-6openalex-snapshot
Interpretations of the Term “Actionable” when Discussing Genetic Test Results: What you Mean Is Not What I Heard
inferred← citeshttps://doi.org/10.1007/s11523-021-00795-5openalex-snapshot
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
inferred← citeshttps://doi.org/10.1007/s11888-018-0410-0openalex-snapshot
Evolving Tissue and Circulating Biomarkers as Prognostic and Predictive Tools in Colorectal Cancer
inferred← citeshttps://doi.org/10.1007/s11912-021-01137-4openalex-snapshot
Circulating Tumour DNA and Colorectal Cancer: the Next Revolutionary Biomarker?
inferred← citeshttps://doi.org/10.1007/s12672-025-02220-zopenalex-snapshot
Circulating tumor DNA in colorectal cancer: biology, methods and applications
inferred← citeshttps://doi.org/10.1007/s15015-018-3816-2openalex-snapshot
Liquid Biopsy beim Kolonkarzinom
inferred← citeshttps://doi.org/10.1016/j.arcmed.2018.10.007openalex-snapshot
Clinical Interest of Circulating Tumor DNA in Oncology
inferred← citeshttps://doi.org/10.1016/j.banm.2025.03.009openalex-snapshot
Intérêt de la détection de l’ADN tumoral circulant dans les cancers colorectaux en 2025
inferred← citeshttps://doi.org/10.1016/j.bbcan.2026.189617openalex-snapshot
Understanding tumor heterogeneity: Implications for precision oncology and therapeutic strategies
inferred← citeshttps://doi.org/10.1016/j.bulcan.2020.04.017openalex-snapshot
Cancers colorectaux avec mutation V600E de BRAF : où en sommes-nous ?
inferred← citeshttps://doi.org/10.1016/j.bulcan.2026.05.008openalex-snapshot
Recommandations nationales du GFCO sur l’analyse de l’ADN tumoral circulant par biopsie liquide pour le diagnostic et la progression du cancer : bonnes pratiques pré-analytiques, analytiques et post-analytiques
inferred← citeshttps://doi.org/10.1016/j.canrad.2018.06.018openalex-snapshot
ADN tumoral circulant : principes, applications actuelles en radiothérapie et développement futur
inferred← citeshttps://doi.org/10.1016/j.clcc.2018.10.004openalex-snapshot
Plasma Dynamics of RAS/RAF Mutations in Patients With Metastatic Colorectal Cancer Receiving Chemotherapy and Anti-EGFR Treatment
inferred← citeshttps://doi.org/10.1016/j.clinre.2018.03.002openalex-snapshot
Role of circulating tumor DNA in the management of patients with colorectal cancer
inferred← citeshttps://doi.org/10.1016/j.clinre.2022.101888openalex-snapshot
MiR-31-3p do not predict anti-EGFR efficacy in first-line therapy of RAS wild-type metastatic right-sided colon cancer
inferred← citeshttps://doi.org/10.1016/j.ctrv.2018.07.007openalex-snapshot
The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios
inferred← citeshttps://doi.org/10.1016/j.ebiom.2023.104564openalex-snapshot
bITH, a blood-based metric of intratumor heterogeneity, is associated with clinical response to immune checkpoint blockade in non-small cell lung cancer
inferred← citeshttps://doi.org/10.1016/j.ejca.2023.113396openalex-snapshot
Negative hyperselection of elderly patients with RAS and BRAF wild-type metastatic colorectal cancer receiving initial panitumumab plus FOLFOX or 5-FU/LV
inferred← citeshttps://doi.org/10.1016/j.ejca.2025.116097openalex-snapshot
Characterization of the cell-free DNA released by tumor organoids derived from colorectal cancer patients
inferred← citeshttps://doi.org/10.1016/j.ejrad.2022.110640openalex-snapshot
Current status and quality of radiomic studies for predicting KRAS mutations in colorectal cancer patients: A systematic review and meta‑analysis
inferred← citeshttps://doi.org/10.1016/j.isci.2022.103826openalex-snapshot
Association of neutrophil extracellular traps with the production of circulating DNA in patients with colorectal cancer
inferred← citeshttps://doi.org/10.1016/j.jmoldx.2020.04.210openalex-snapshot
Detection of Microsatellite Instability from Circulating Tumor DNA by Targeted Deep Sequencing
inferred← citeshttps://doi.org/10.1016/j.preme.2024.100006openalex-snapshot
Intratumor heterogeneity in breast cancer: Tracing its origins and translating findings into clinical practice
inferred← citeshttps://doi.org/10.1016/j.tranon.2018.07.013openalex-snapshot
Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing
inferred← citeshttps://doi.org/10.1016/j.tranon.2018.11.015openalex-snapshot
Advantage of Next-Generation Sequencing in Dynamic Monitoring of Circulating Tumor DNA over Droplet Digital PCR in Cetuximab Treated Colorectal Cancer Patients
inferred← citeshttps://doi.org/10.1038/nrclinonc.2017.166openalex-snapshot
Tumour heterogeneity and resistance to cancer therapies
inferred← citeshttps://doi.org/10.1038/s41416-018-0293-5openalex-snapshot
Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer
inferred← citeshttps://doi.org/10.1038/s41416-019-0716-yopenalex-snapshot
Hypoxia differently modulates the release of mitochondrial and nuclear DNA
inferred← citeshttps://doi.org/10.1038/s41416-021-01431-9openalex-snapshot
CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC)
inferred← citeshttps://doi.org/10.1038/s41525-018-0069-0openalex-snapshot
New insights into structural features and optimal detection of circulating tumor DNA determined by single-strand DNA analysis
inferred← citeshttps://doi.org/10.1038/s41585-020-0304-1openalex-snapshot
Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes
inferred← citeshttps://doi.org/10.1038/s41598-019-41593-4openalex-snapshot
Quantifying circulating cell-free DNA in humans
inferred← citeshttps://doi.org/10.1038/s41598-019-45616-yopenalex-snapshot
Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples
inferred← citeshttps://doi.org/10.1038/s41598-020-63180-8openalex-snapshot
A comparative study of extracellular vesicle-associated and cell-free DNA and RNA for HPV detection in oropharyngeal squamous cell carcinoma
inferred← citeshttps://doi.org/10.1093/annonc/mdy017openalex-snapshot
Circulating tumour DNA analyses reveal novel resistance mechanisms to CDK inhibition in metastatic breast cancer
inferred← citeshttps://doi.org/10.1093/annonc/mdy061openalex-snapshot
RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study
inferred← citeshttps://doi.org/10.1093/annonc/mdy091openalex-snapshot
Detection of somatic RAS mutations in circulating tumor DNA from metastatic colorectal cancer patients: are we ready for clinical use?
inferred← citeshttps://doi.org/10.1093/annonc/mdz031openalex-snapshot
Recent advances in circulating nucleic acids in oncology
inferred← citeshttps://doi.org/10.1093/bib/bbaa402openalex-snapshot
MSIsensor-ct: microsatellite instability detection using cfDNA sequencing data
inferred← citeshttps://doi.org/10.1093/bjs/znad126openalex-snapshot
Circulating tumour DNA in colorectal cancer management
inferred← citeshttps://doi.org/10.1093/nar/gkz067openalex-snapshot
Structural variation and fusion detection using targeted sequencing data from circulating cell free DNA
inferred← citeshttps://doi.org/10.1093/pcmedi/pbae008openalex-snapshot
Association of the immediate perioperative dynamics of circulating DNA levels and neutrophil extracellular traps formation in cancer patients
inferred← citeshttps://doi.org/10.1097/md.0000000000028382openalex-snapshot
Reliability of BRAF mutation detection using plasma sample
inferred← citeshttps://doi.org/10.1134/s0006297923070118openalex-snapshot
The Effect of Cell-Free DNA from Blood Serum of Mice with Metastatic Melanoma on Enhancement of Oncogenic Properties of Melanoma Cells
inferred← citeshttps://doi.org/10.1136/jclinpath-2018-205471openalex-snapshot
RAS genes in colorectal carcinoma: pathogenesis, testing guidelines and treatment implications
inferred← citeshttps://doi.org/10.1148/radiol.2019182584openalex-snapshot
Liquid Biopsy for Cancer: Review and Implications for the Radiologist
inferred← citeshttps://doi.org/10.1158/1078-0432.c.6531329openalex-snapshot
Data from The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer
inferred← citeshttps://doi.org/10.1158/1078-0432.c.6531329.v1openalex-snapshot
Data from The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-17-3103openalex-snapshot
Hybrid Capture–Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-18-1128openalex-snapshot
Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-18-3769openalex-snapshot
miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-20-4699openalex-snapshot
The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer
inferred← citeshttps://doi.org/10.1158/1535-7163.mct-18-0965openalex-snapshot
Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics
inferred← citeshttps://doi.org/10.1158/1541-7786.mcr-19-0768openalex-snapshot
Current Perspectives on Circulating Tumor DNA, Precision Medicine, and Personalized Clinical Management of Cancer
inferred← citeshttps://doi.org/10.1172/jci.insight.144561openalex-snapshot
Circulating nuclear DNA structural features, origins, and complete size profile revealed by fragmentomics
inferred← citeshttps://doi.org/10.1177/0004563218798401openalex-snapshot
Circulating tumour DNA as a cancer biomarker
inferred← citeshttps://doi.org/10.1177/1758835919856494openalex-snapshot
Molecular targeted therapy of BRAF -mutant colorectal cancer
inferred← citeshttps://doi.org/10.1177/1758835920918472openalex-snapshot
Early identification of treatment benefit by methylated circulating tumor DNA in metastatic colorectal cancer
inferred← citeshttps://doi.org/10.1186/s12885-020-07516-7openalex-snapshot
Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients
inferred← citeshttps://doi.org/10.1186/s13045-021-01166-3openalex-snapshot
Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes
inferred← citeshttps://doi.org/10.1186/s13046-018-0723-5openalex-snapshot
Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma
inferred← citeshttps://doi.org/10.1186/s13046-023-02743-9openalex-snapshot
Network approach in liquidomics landscape
inferred← citeshttps://doi.org/10.1186/s13148-021-01182-7openalex-snapshot
Guidelines for pre-analytical conditions for assessing the methylation of circulating cell-free DNA
inferred← citeshttps://doi.org/10.1200/edbk_199765openalex-snapshot
Liquid Biopsy to Identify Actionable Genomic Alterations
inferred← citeshttps://doi.org/10.1200/po.18.00158openalex-snapshot
Genomic Assessment of Blood-Derived Circulating Tumor DNA in Patients With Colorectal Cancers: Correlation With Tissue Sequencing, Therapeutic Response, and Survival
inferred← citeshttps://doi.org/10.1200/po.18.00162openalex-snapshot
Correlation Between Tumor-Specific Mutated and Methylated DNA in Colorectal Cancer
inferred← citeshttps://doi.org/10.1200/po.19.00400openalex-snapshot
UndetectableRAS-Mutant Clones in Plasma: Possible Implication for Anti-EGFR Therapy and Prognosis in Patients WithRAS-Mutant Metastatic Colorectal Cancer
inferred← citeshttps://doi.org/10.1200/po.21.00383openalex-snapshot
Clinical Validity of Plasma-Based Genotyping for Microsatellite Instability Assessment in Advanced GI Cancers: SCRUM-Japan GOZILA Substudy
inferred← citeshttps://doi.org/10.1371/journal.pone.0227294openalex-snapshot
Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer
inferred← citeshttps://doi.org/10.1634/theoncologist.2017-0621openalex-snapshot
Clinical Utility of Analyzing Circulating Tumor DNA in Patients with Metastatic Colorectal Cancer
inferred← citeshttps://doi.org/10.17650/2686-9594-2022-12-1-27-34openalex-snapshot
Concordance between the tumor mutational status and circulating tumor DNA in patients with colorectal cancer
inferred← citeshttps://doi.org/10.17925/ohr.2019.15.1.33openalex-snapshot
Circulating Tumor DNA in Colorectal Cancer—From Concept to Clinic
inferred← citeshttps://doi.org/10.20517/2394-4722.2021.61openalex-snapshot
Research progress on KRAS mutations in colorectal cancer
inferred← citeshttps://doi.org/10.21203/rs.3.rs-91128/v1openalex-snapshot
Concordance of Acquired Mutations between Metastatic Lesions and Liquid Biopsy in Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
inferred← citeshttps://doi.org/10.21294/1814-4861-2021-20-5-149-161openalex-snapshot
THE IMPORTANCE OF CIRCULATING TUMOR DNA IN THE ASSESSMENT OF METASTATIC COLORECTAL CANCER TREATMENT EFFECTIVNE
inferred← citeshttps://doi.org/10.2144/fsoa-2021-0059openalex-snapshot
Concordance of Acquired Mutations between Metastatic Lesions and Liquid Biopsy in Metastatic Colorectal Cancer
inferred← citeshttps://doi.org/10.2147/ott.s535858openalex-snapshot
Diagnosis and Management of Colorectal Cancer in the Gulf Area: Current Practice and Future Suggestions from Expert Opinions
inferred← citeshttps://doi.org/10.2174/0115680096295070240318075023openalex-snapshot
Early Detection, Precision Treatment, Recurrence Monitoring: Liquid Biopsy Transforms Colorectal Cancer Therapy
inferred← citeshttps://doi.org/10.2174/1381612826666201007163116openalex-snapshot
The Clinical Impact of Quantitative Cell-free DNA, KRAS, and BRAF Mutations on Response to Anti-EGFR Treatment in Patients with Metastatic Colorectal Cancer
inferred← citeshttps://doi.org/10.21926/obm.genet.2003openalex-snapshot
inferred← citeshttps://doi.org/10.21926/obm.genet.2003114openalex-snapshot
Detection of Circulating Tumor DNA in Solid Tumors
inferred← citeshttps://doi.org/10.31857/s0320972523070114openalex-snapshot
Impact of cell-free dna from blood serum of mice with metastatic melanoma on the enhancement of oncogenic properties of melanoma cells
inferred← citeshttps://doi.org/10.3389/fgene.2021.811291openalex-snapshot
Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal Cancer
inferred← citeshttps://doi.org/10.3389/fonc.2019.00170openalex-snapshot
Circulating Tumor DNA Detection in the Management of Anti-EGFR Therapy for Advanced Colorectal Cancer
inferred← citeshttps://doi.org/10.3390/bios16060309openalex-snapshot
Robotic Centrifugal Microfluidics with In-Rotation Liquid Supply for the Extraction of Multiple Liquid Biopsy Analytes in One Platform
inferred← citeshttps://doi.org/10.3390/cancers11070998openalex-snapshot
BRAF Mutation Status in Circulating Tumor DNA from Patients with Metastatic Colorectal Cancer: Extended Mutation Analysis from the AGEO RASANC Study
inferred← citeshttps://doi.org/10.3390/cancers11101504openalex-snapshot
Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience
inferred← citeshttps://doi.org/10.3390/cancers11121938openalex-snapshot
Assessing the Concordance of Genomic Alterations between Circulating-Free DNA and Tumour Tissue in Cancer Patients
inferred← citeshttps://doi.org/10.3390/cancers13164190openalex-snapshot
Postoperative Circulating Tumor DNA Can Predict High Risk Patients with Colorectal Cancer Based on Next-Generation Sequencing
inferred← citeshttps://doi.org/10.3390/cancers15041284openalex-snapshot
The Position of Circulating Tumor DNA in the Clinical Management of Colorectal Cancer
inferred← citeshttps://doi.org/10.3390/cancers15143578openalex-snapshot
Clinicopathological Profiles Associated with Discordant RAS Mutational Status between Liquid and Tissue Biopsies in a Real-World Cohort of Metastatic Colorectal Cancer
inferred← citeshttps://doi.org/10.3390/ijms19123733openalex-snapshot
Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?
inferred← citeshttps://doi.org/10.3390/ijms26157619openalex-snapshot
Navigating the Landscape of Liquid Biopsy in Colorectal Cancer: Current Insights and Future Directions
inferred← citeshttps://doi.org/10.3390/jcm10010087openalex-snapshot
Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients—The Importance of Tissue/Plasma Discordant Cases
inferred← citeshttps://doi.org/10.3390/jpm12010099openalex-snapshot
Use of Circulating Tumour DNA (ctDNA) for Measurement of Therapy Predictive Biomarkers in Patients with Cancer
inferred← citeshttps://doi.org/10.3892/mco.2021.2434openalex-snapshot
Liquid biopsy: Novel perspectives on the importance and spectrum of PIK3CA, PTEN and RET mutations in solid tumors
inferred← citeshttps://doi.org/10.6004/jnccn.2023.7011openalex-snapshot
Private Payer and Medicare Coverage Policies for Use of Circulating Tumor DNA Tests in Cancer Diagnostics and Treatment
inferred← citeshttps://doi.org/10.6084/m9.figshare.13106241openalex-snapshot
Additional file 1 of Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients
inferred← citeshttps://doi.org/10.70675/0b7bdb5azf42fz42d0z856dz67e069b5b290openalex-snapshot
Détection de l'ADN circulant chez le sujet sain et le patient atteint d'un cancer métastatique par PCR digitale en gouttelettes
inferred← citeshttps://doi.org/10.70675/43aaefbdz9b84z4530z9f7az31734d0d3d36openalex-snapshot
Détection et quantification de l'ADN circulant : conditions pré-analytiques et applications pour le suivi des patients atteints de cancer colorectal
inferred← citeshttps://doi.org/10.70675/440c7edcz62d4z4a0fzac48z88fe67ce18bbopenalex-snapshot
Instability of Microsatellites and Cancer : Taking Advantage of Next Generation Sequencing for the Identification of this Tumor Phenotype and the Analysis of the Mechanisms of Resistance to Immunotherapy
inferred← citeshttps://doi.org/10.70675/8db97ab9zf3b5z4de3za6ccz9d08aa2ef35copenalex-snapshot
ADN tumoral circulant : aspects analytiques et intérêt dans la prise en charge des patients atteints de mélanome cutané métastatique
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.